InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Malin Life Sciences Holdings Ltd. Director active across 1 company, notably Poseida Therapeutics, Inc.. Cumulatively, 10 reports have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €877k. Activity tracked since 16 November 2021. The latest transaction was disclosed on 6 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
1,828 shares@ US$6.902.5% of flowCOMMON STOCKSEC:0001104659-21-146952
Ideal exit: 2 Sept 2022 (T+270)
1,828 shares@ US$6.901.3% of flowCOMMON STOCKSEC:0001104659-21-146952:0
Ideal exit: 2 Sept 2022 (T+270)
28,592 shares@ US$6.849419.8% of flowCOMMON STOCKSEC:0001104659-21-146000:0
Ideal exit: 27 Aug 2022 (T+270)
28,592 shares@ US$6.849439.6% of flowCOMMON STOCKSEC:0001104659-21-146000
Ideal exit: 27 Aug 2022 (T+270)
1,054 shares@ US$6.88820.7% of flowCOMMON STOCKSEC:0001104659-21-144590:0
Ideal exit: 21 Aug 2022 (T+270)
1,054 shares@ US$6.88821.5% of flowCOMMON STOCKSEC:0001104659-21-144590
Ideal exit: 21 Aug 2022 (T+270)
11,104 shares@ US$7.44338.3% of flowCOMMON STOCKSEC:0001104659-21-143142:0
Ideal exit: 16 Aug 2022 (T+270)
11,104 shares@ US$7.443316.6% of flowCOMMON STOCKSEC:0001104659-21-143142
Ideal exit: 16 Aug 2022 (T+270)
27,680 shares@ US$7.16739.8% of flowCOMMON STOCKSEC:0001104659-21-141457
Ideal exit: 13 Aug 2022 (T+270)
27,680 shares@ US$7.16719.9% of flowCOMMON STOCKSEC:0001104659-21-141457:0
Ideal exit: 13 Aug 2022 (T+270)
10 of 10 declarations
About Malin Life Sciences Holdings Ltd
Malin Life Sciences Holdings Ltd is a director at Poseida Therapeutics, Inc.
